Oncolytics Biotech Inc.
ONCY · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $100,507 | $118,178 | $128,087 | $94,026 |
| - Cash | $15,942 | $34,912 | $11,666 | $41,262 |
| + Debt | $1,064 | $423 | $373 | $655 |
| Enterprise Value | $85,629 | $83,689 | $116,794 | $53,419 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$299 | -$301 | -$361 |
| % Margin | – | – | – | – |
| EBITDA | -$34,880 | -$20,191 | -$18,711 | -$20,581 |
| % Margin | – | – | – | – |
| Net Income | -$31,710 | -$20,562 | -$19,077 | -$20,981 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.41 | -0.41 | -0.43 | -0.49 |
| % Growth | 0% | 4.7% | 12.2% | – |
| Operating Cash Flow | -$26,966 | -$28,448 | -$23,355 | -$22,434 |
| Capital Expenditures | -$239 | -$8 | -$55 | -$286 |
| Free Cash Flow | -$27,205 | -$28,456 | -$23,410 | -$22,720 |